Jones Financial Companies Lllp Acquires 72,121 Shares of Kenvue Inc. $KVUE

Jones Financial Companies Lllp grew its stake in shares of Kenvue Inc. (NYSE:KVUE) by 14.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 572,013 shares of the company’s stock after purchasing an additional 72,121 shares during the quarter. Jones Financial Companies Lllp’s holdings in Kenvue were worth $9,392,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in KVUE. TrueMark Investments LLC increased its holdings in Kenvue by 8.8% during the 2nd quarter. TrueMark Investments LLC now owns 229,648 shares of the company’s stock worth $4,807,000 after purchasing an additional 18,623 shares during the period. Vanguard Group Inc. increased its stake in shares of Kenvue by 1.8% during the second quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock valued at $4,881,844,000 after buying an additional 4,101,880 shares during the period. OFI Invest Asset Management raised its holdings in shares of Kenvue by 705.6% in the second quarter. OFI Invest Asset Management now owns 26,979 shares of the company’s stock valued at $565,000 after acquiring an additional 23,630 shares in the last quarter. Simplicity Wealth LLC purchased a new stake in Kenvue in the second quarter worth about $507,000. Finally, Aberdeen Group plc lifted its stake in Kenvue by 15.1% in the second quarter. Aberdeen Group plc now owns 766,450 shares of the company’s stock worth $16,015,000 after acquiring an additional 100,403 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of Kenvue stock in a transaction that occurred on Friday, December 12th. The stock was bought at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. The trade was a 13.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 1.68% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on KVUE. Evercore ISI set a $18.00 price objective on shares of Kenvue in a research note on Tuesday, October 28th. Johnson Rice reiterated a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Bank of America decreased their price objective on Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Canaccord Genuity Group reiterated a “hold” rating and issued a $15.00 target price (down previously from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. Finally, Barclays increased their price target on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $19.90.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $17.99 on Thursday. The company has a 50 day simple moving average of $17.20 and a two-hundred day simple moving average of $17.93. The stock has a market cap of $34.47 billion, a price-to-earnings ratio of 23.99 and a beta of 0.59. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The company had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The firm’s quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.28 earnings per share. As a group, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.6%. Kenvue’s dividend payout ratio is presently 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.